{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:52:15Z","timestamp":1761709935964},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,22]]},"DOI":"10.7759\/cureus.21503","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T06:49:12Z","timestamp":1642920552000},"source":"Crossref","is-referenced-by-count":1,"title":["Inter-Fractional Variations in Volume and Radiation Dose to the Organs at Risk, High-Risk Clinical Target Volume and Implication of Image-Guided Adaptive Planning During Intracavitary Brachytherapy of Carcinoma Cervix"],"prefix":"10.7759","author":[{"given":"Gurubasappa","family":"Patil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran Kumar","family":"BR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-249. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001000","article-title":"Systematic review and network meta-analysis of bevacizumab plus first-line topotecan-paclitaxel or cisplatin-paclitaxel versus non-bevacizumab-containing therapies in persistent, recurrent, or metastatic cervical cancer","volume":"27","author":"Rosen VM","year":"2017","unstructured":"Rosen VM, Guerra I, McCormack M, Nogueira-Rodrigues A, Sasse A, Munk VC, Shang A. Systematic review and network meta-analysis of bevacizumab plus first-line topotecan-paclitaxel or cisplatin-paclitaxel versus non-bevacizumab-containing therapies in persistent, recurrent, or metastatic cervical cancer. Int J Gynecol Cancer. 2017, 27:1237-1246. 10.1097\/IGC.0000000000001000","journal-title":"Int J Gynecol Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90316-v","article-title":"Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation","volume":"21","author":"Orton CG","year":"1991","unstructured":"Orton CG, Seyedsadr M, Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 1991, 21:1425-1434. 10.1016\/0360-3016(91)90316-v","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/687365","article-title":"Magnitude and implications of interfraction variations in organ doses during high dose rate brachytherapy of cervix cancer: a CT based planning study","volume":"2014","author":"Chakraborty S","year":"2014","unstructured":"Chakraborty S, Patel FD, Patil VM, Oinam AS, Sharma SC. Magnitude and implications of interfraction variations in organ doses during high dose rate brachytherapy of cervix cancer: a CT based planning study. ISRN Oncol. 2014, 2014:687365. 10.1155\/2014\/687365","journal-title":"ISRN Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-3947(00)00032-7","article-title":"Point dose variations with time during traditional brachytherapy for cervical carcinoma","volume":"25","author":"King GC","year":"2000","unstructured":"King GC, Bloomer WD, Kalnicki S, et al.. Point dose variations with time during traditional brachytherapy for cervical carcinoma. Med Dosim. 2000, 25:77-80. 10.1016\/S0958-3947(00)00032-7","journal-title":"Med Dosim"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90691-a","article-title":"High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations","volume":"24","author":"Thomadsen BR","year":"1992","unstructured":"Thomadsen BR, Shahabi S, Stitt JA, et al.. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations. Int J Radiat Oncol Biol Phys. 1992, 24:349-357. 10.1016\/0360-3016(92)90691-a","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.09.090","article-title":"Significant rectal and bladder dose reduction via utilization of Foley balloon catheters in high-dose-rate tandem and ovoid intracavitary brachytherapy of the uterine cervix","volume":"59","author":"Eng TY","year":"2004","unstructured":"Eng TY, Fuller CD, Cavanaugh SX, Blough MM, Sadeghi A, Herman T. Significant rectal and bladder dose reduction via utilization of Foley balloon catheters in high-dose-rate tandem and ovoid intracavitary brachytherapy of the uterine cervix. Int J Radiat Oncol Biol Phys. 2004, 59:174-178. 10.1016\/j.ijrobp.2003.09.090","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.195.2.7724760","article-title":"Major geometric variations between multiple high-dose-rate applications of brachytherapy in cancer of the cervix: frequency and types of variation","volume":"195","author":"Kim RY","year":"1995","unstructured":"Kim RY, Meyer JT, Plott WE, Spencer SA, Meredith RF, Jennelle RL, Salter MM. Major geometric variations between multiple high-dose-rate applications of brachytherapy in cancer of the cervix: frequency and types of variation. Radiology. 1995, 195:419-422. 10.1148\/radiology.195.2.7724760","journal-title":"Radiology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2014.10.006","article-title":"Need for radiotherapy in low and middle income countries - the silent crisis continues","volume":"27","author":"Zubizarreta EH","year":"2015","unstructured":"Zubizarreta EH, Fidarova E, Healy B, Rosenblatt E. Need for radiotherapy in low and middle income countries - the silent crisis continues. Clin Oncol (R Coll Radiol). 2015, 27:107-114. 10.1016\/j.clon.2014.10.006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref10","unstructured":"National Comprehensive Cancer Network. Cervical Cancer. (2015). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.02.002","article-title":"Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer","volume":"76","author":"Kim RY","year":"2010","unstructured":"Kim RY, Shen S, Lin HY, Spencer SA, De Los Santos J. Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2010, 76:485-489. 10.1016\/j.ijrobp.2009.02.002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter R","year":"2006","unstructured":"P\u00f6tter R, Haie-Meder C, Van Limbergen E, et al.. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006, 78:67-77. 10.1016\/j.radonc.2005.11.014","journal-title":"Radiother Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles","volume":"11","author":"Viswanathan AN","year":"2012","unstructured":"Viswanathan AN, Thomadsen B. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy. 2012, 11:33-46. 10.1016\/j.brachy.2011.07.003","journal-title":"Brachytherapy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20140018","article-title":"Image-guided high-dose-rate brachytherapy in inoperable endometrial cancer","volume":"87","author":"Dankulchai P","year":"2014","unstructured":"Dankulchai P, Petsuksiri J, Chansilpa Y, Hoskin PJ. Image-guided high-dose-rate brachytherapy in inoperable endometrial cancer. Br J Radiol. 2014, 87:20140018. 10.1259\/bjr.20140018","journal-title":"Br J Radiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5114\/jcb.2015.50720","article-title":"A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer","volume":"7","author":"Okuma K","year":"2015","unstructured":"Okuma K, Yamashita H, Kobayashi R, Nakagawa K. A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer. J Contemp Brachytherapy. 2015, 7:128-134. 10.5114\/jcb.2015.50720","journal-title":"J Contemp Brachytherapy"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5114\/jcb.2014.42021","article-title":"Image guided adaptive brachytherapy for cervical cancer: dose contribution to involved pelvic nodes in two cancer centers","volume":"6","author":"van den Bos W","year":"2014","unstructured":"van den Bos W, Beriwal S, Velema L, de Leeuw AA, Nomden CN, J\u00fcrgenliemk-Schulz IM. Image guided adaptive brachytherapy for cervical cancer: dose contribution to involved pelvic nodes in two cancer centers. J Contemp Brachytherapy. 2014, 6:21-27. 10.5114\/jcb.2014.42021","journal-title":"J Contemp Brachytherapy"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder C","year":"2005","unstructured":"Haie-Meder C, P\u00f6tter R, Van Limbergen E, et al.. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005, 74:235-245. 10.1016\/j.radonc.2004.12.015","journal-title":"Radiother Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90402-h","article-title":"Anatomic variation of gynecologic brachytherapy prescription points","volume":"27","author":"Grigsby PW","year":"1993","unstructured":"Grigsby PW, Georgiou A, Williamson JF, Perez CA. Anatomic variation of gynecologic brachytherapy prescription points. Int J Radiat Oncol Biol Phys. 1993, 27:725-729. 10.1016\/0360-3016(93)90402-h","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8140(96)01746-x","article-title":"Changes in applicator position with fractionated high dose rate gynaecological brachytherapy","volume":"40","author":"Hoskin PJ","year":"1996","unstructured":"Hoskin PJ, Cook M, Bouscale D, Cansdale J. Changes in applicator position with fractionated high dose rate gynaecological brachytherapy. Radiother Oncol. 1996, 40:59-62. 10.1016\/0167-8140(96)01746-x","journal-title":"Radiother Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(96)00187-3","article-title":"Major geometric variations between intracavitary applications in carcinoma of the cervix: high dose rate vs. low dose rate","volume":"35","author":"Kim RY","year":"1996","unstructured":"Kim RY, Meyer JT, Spencer SA, Meredith RF, Jennelle RL, Salter MM. Major geometric variations between intracavitary applications in carcinoma of the cervix: high dose rate vs. low dose rate. Int J Radiat Oncol Biol Phys. 1996, 35:1035-1038. 10.1016\/0360-3016(96)00187-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2009.06.032","article-title":"Sigmoid dose using 3D imaging in cervical-cancer brachytherapy","volume":"93","author":"Holloway CL","year":"2009","unstructured":"Holloway CL, Racine ML, Cormack RA, O'Farrell DA, Viswanathan AN. Sigmoid dose using 3D imaging in cervical-cancer brachytherapy. Radiother Oncol. 2009, 93:307-310. 10.1016\/j.radonc.2009.06.032","journal-title":"Radiother Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2011.07.002","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy","volume":"11","author":"Viswanathan AN","year":"2012","unstructured":"Viswanathan AN, Beriwal S, De Los Santos J, et al.. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012, 11:47-52. 10.1016\/j.brachy.2011.07.002","journal-title":"Brachytherapy"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter R","year":"2021","unstructured":"P\u00f6tter R, Tanderup K, Schmid MP, et al.. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021, 22:538-547. 10.1016\/S1470-2045(20)30753-1","journal-title":"Lancet Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.06.010","article-title":"Magnetic resonance image guided adaptive brachytherapy in locally advanced cervical cancer: an experience from a tertiary cancer center in a low and middle income countries setting","volume":"99","author":"Mahantshetty U","year":"2017","unstructured":"Mahantshetty U, Krishnatry R, Hande V, et al.. Magnetic resonance image guided adaptive brachytherapy in locally advanced cervical cancer: an experience from a tertiary cancer center in a low and middle income countries setting. Int J Radiat Oncol Biol Phys. 2017, 99:608-617. 10.1016\/j.ijrobp.2017.06.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4103\/jmp.JMP_90_17","article-title":"Interfraction variations in organ filling and their impact on dosimetry in CT image based HDR intracavitary brachytherapy","volume":"43","author":"Rangarajan R","year":"2018","unstructured":"Rangarajan R. Interfraction variations in organ filling and their impact on dosimetry in CT image based HDR intracavitary brachytherapy. J Med Phys. 2018, 43:23-27. 10.4103\/jmp.JMP_90_17","journal-title":"J Med Phys"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2013.02.003","article-title":"A dosimetric evaluation of using a single treatment plan for multiple treatment fractions within a given applicator insertion in gynecologic brachytherapy","volume":"12","author":"Pinnaduwage DS","year":"2013","unstructured":"Pinnaduwage DS, Cunha JA, Weinberg V, Krishnamurthy D, Nash M, Hsu IC, Pouliot J. A dosimetric evaluation of using a single treatment plan for multiple treatment fractions within a given applicator insertion in gynecologic brachytherapy. Brachytherapy. 2013, 12:487-494. 10.1016\/j.brachy.2013.02.003","journal-title":"Brachytherapy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/83849-inter-fractional-variations-in-volume-and-radiation-dose-to-the-organs-at-risk-high-risk-clinical-target-volume-and-implication-of-image-guided-adaptive-planning-during-intracavitary-brachytherapy-of-carcinoma-cervix","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:15Z","timestamp":1707507795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/83849-inter-fractional-variations-in-volume-and-radiation-dose-to-the-organs-at-risk-high-risk-clinical-target-volume-and-implication-of-image-guided-adaptive-planning-during-intracavitary-brachytherapy-of-carcinoma-cervix"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,22]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.21503","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,22]]}}}